Program Description: 

Advances in imaging technology have enabled the measurement of retinal structures mediating visual function.  Visual function can be assessed through psychophysical and electrophysiological tests and the relationship between measurements of retinal structures and visual function provides insight into the functioning of the visual system.  The lecture will cover developments in the understanding of structure/function relationships as imaging technology has advanced.

Accreditation Statement:

The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 
AMA Credit Designation:
The Medical College of Wisconsin designates this Live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Hours of Participation for Allied Health Professionals:
The Medical College of Wisconsin designates this activity for up to 1.25 hours of participation for continuing education for allied health professionals.
Target audience: 
  • Community eye care providers
  • Full-time faculty
  • Residents
  • Fellow ophthalmologists
  • Optometrists
  • Ophthalmic photographers
Learning objectives: 

1.    To understand the considerations in selecting suitable clinical trial outcome measures.

2.    To appreciate the role of intraocular pressure (IOP) in glaucoma progression and factors confounding the observed association between IOP measurement and visual field progression.

3.   To understand the potential role of quantitative imaging in glaucoma trial..

Faculty & credentials: 
Planning Committee Members:
Wanda M. Martinez, MD
Bhavna P. Sheth, MD
 
Speaker Info:
David Garway-Heath, MD, FRCOphth
IGA Professor of Ophthalmology for Glaucoma and Allied Studies 
Moorfields Eye Hospital and UCL Institute of Ophthalmology
London, England
 
All persons in control of content has NO relevant financial relationships to disclose with the exception of the following persons:
 
David Garway-Heath, MD
 
Commercial Interests:
Heidelberg Engineering as an Investigator
OptoVue as an Investigator
Alcon as a Speaker
Alimera as a Speaker
Allergan as an Advisor/Speaker 
Bausch & Lomb as a Speaker
Forsight as a Speaker
Glaxo Smith Kline as a Speaker
Merck Sharp & Dohme as a Speaker 
Quark as a Speaker
 
 

 

Contact

Name: 
Hattie Waagen
Phone number: 
+1 (414) 955-7842
Email: 
hwaagen@mcw.edu
Session date: 
02/05/2014 - 7:00am to 8:15am CST
Location: 
Eye Institute
925 N. 87th Street
Milwaukee, WI 53226
United States
See map: Google Maps
Add to calendar: 
  • 1.25 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.25 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.